Actinium Pharmaceuticals to hold a conference call
Conference call to provide an update on the Pivotal Phase 3 SIERRA Trial (Study of Iomab-B in Elderly Relapsed/Refractory AML) of Iomab-B will be held on August 15 at 9 am. Weblink: https://onecast.thinkpragmatic.com/ses/HKwlrC68IHB_UiNbwrpb4w~~
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.